Steven L. Colletti

Statistics

Publications

Citations

4.3K

H-Index

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Arena Pharmaceuticals (United States)

United States Military Academy

Steven L. Colletti is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1989–2018

Publications

Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase

Sandra J. Darkin‐Rattray, Anne Gurnett, Robert W. Myers et al. · Proceedings of the National Academy of Sciences · 1996 · 572 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds

Yong Yao Loh, Kazunori Nagao, Andrew J. Hoover et al. · Science · 2017 · 571 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

Discovery of platencin, a dual FabF and FabH inhibitor with <i>in vivo</i> antibiotic properties

Jun Wang, Srinivas Kodali, Sang Ho Lee et al. · Proceedings of the National Academy of Sciences · 2007 · 380 citations · Full text

Life Sciences, Microbiology, Pharmacology +14

Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40

Jun Lu, Noel Byrne, John Wang et al. · Nature Structural & Molecular Biology · 2017 · 194 citations

Life Sciences, Biochemistry, Molecular Biology +16

Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation

Younong Yu, Li‐Kang Zhang, Alexei V. Buevich et al. · Journal of the American Chemical Society · 2018 · 140 citations

Pharmacy, Biochemistry, Medicinal Chemistry +13

1–5 of 69